Catalyst Clinical Research Acquires UK CRO Aptus Clinical.

MANews-(C)2009-2022

US-based clinical research services provider Catalyst Clinical Research has acquired UK-based clinical contract research organisation Aptus Clinical to accelerate European expansion, the company said.

Terms of the transaction were not disclosed.

The acquisition will broaden client services and enhance patient impact. The two entities will become one multi-region clinical research organisation with an accelerated growth trajectory in both the US and Europe.

Catalyst's offerings will now encompass extensive and expanded clinical consulting services, as it inherits Aptus' established relationship with the Experimental Cancer Medicine Centre network to support trial set-up and clinical design input.

Catalyst is a clinical development organisation providing...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT